secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2024-02-07T23:59:59+00:00
Accession:  0001193125-24-026615
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex raises ~$3.7M in private placement of common stock and warrants
------------------------------------------------------------------------

- Issues 3.84M shares and warrants for 3.84M shares at $0.725 per unit; also 1.27M pre-funded warrants at $0.7249.
- Common warrants exercisable at $1.00/share; pre-funded warrants at $0.0001; both immediately exercisable.
- Investors include company chair Albert Friedberg (FCMI) and CEO Maurice Zauderer (Vaccinex Rochester).
- Gross proceeds ~$3.7M; closing on Feb 8, 2024.
- Executive officers and directors subject to 45-day lock-up on sales of common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312524026615/0001193125-24-026615-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312524026615/d736760d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-026615

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer